Navigation Links
New biomarker test predicts arthritis at much earlier stage, MU researchers say

COLUMBIA, Mo. More than 27 million adults currently suffer from osteoarthritis, which is the most common form of arthritis. In the past, doctors have been unable to diagnose patients with arthritis until they begin to show symptoms, which include joint pain and stiffness. By the time these symptoms are present, it is often too late for preventive and minimally invasive treatment options to be effective. Now, a research team from the University of Missouri's Comparative Orthopaedic Laboratory has found a way to detect and predict arthritis before patients begin suffering from symptoms.

James Cook, a researcher from the MU College of Veterinary Medicine and the William C. and Kathryn E. Allen Distinguished Professor in Orthopaedic Surgery, along with MU researchers Bridget Garner, Aaron Stoker, Keiichi Kuroki, Cristi Cook, and Prakash Jayabalan, have developed a test using specific biomarkers that can accurately determine if a patient is developing arthritis as well as predict the potential severity of the disease. The test can be run off of a single drop of fluid from a patient's joint, which is obtained with a small needle similar to drawing blood.

"With this biomarker test, we can study the levels of specific proteins that we now know are associated with osteoarthritis," Cook said. "Not only does the test have the potential to help predict future arthritis, but it also tells us about the early mechanisms of arthritis, which will lead to better treatments in the future."

In their study published in the Journal of Knee Surgery, the MU researchers report that they developed the test by analyzing the joints of dogs that suffer from arthritis. Veterinarians predict that 20 percent of middle-aged dogs and 90 percent of older dogs have osteoarthritis in one or more joints. Since canine joints operate similarly to the joints of humans, Cook says the test is being adapted to human patients.

"This test has already shown early usefulness for allowing us to monitor how different treatments affect the arthritic joints in people," Cook said. "With further validation, this test will allow doctors to adjust and fine tune treatments to individual patients. Also, being able to tell patients when they are at a high risk for developing arthritis will give doctors a strong motivational tool to convince patients to take preventive measures including appropriate exercise and diet change."

The biomarker test is currently available for licensing and is in the process of gaining FDA approval.


Contact: Nathan Hurst
University of Missouri-Columbia

Related medicine news :

1. Early biomarker for pancreatic cancer identified
2. Mayo Clinic researchers discover biomarkers for prostate cancer detection, recurrence
3. Biomarkers can reveal IBS
4. SomaLogic publishes proteomic biomarker analysis of lung cancer tissue samples
5. Biomarker identified in relation to drug response in refractory urothelial cancer
6. Panel of serum biomarkers may reduce number of lung biopsies needed
7. Biomarkers identify acute kidney injury in emergency patients
8. Genetic sequencing could help match patients with biomarker-driven cancer trials, treatments
9. Metabolic syndrome biomarkers predict lung function impairment after exposure to WTC dust
10. Mass. General Cancer Center and Vall dHebron Institute of Oncology biomarker alliance
11. Neurologists identify potential biomarker of cognitive decline for earlier diagnosis of disease
Post Your Comments:
(Date:10/13/2017)... ... 13, 2017 , ... While it’s often important to take certain medications during ... Austin, Texas, has identified a solution. , She developed a prototype for MOTION LIGHT-UP ... such, it eliminates the need to turn on a light when taking medication during ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the ... national organization of elder law and special needs planning attorneys. “Membership in ElderCounsel helps ... provides a forum to network with elder law attorneys nationwide,” said Somekh. , ...
(Date:10/13/2017)... ... ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out many kids this ... by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting kids excited about ... ages; it is a non-competitive, non-timed event, which is all about having fun and ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history of ... Brink” is the creation of published author, William Nowers. Captain Nowers and his ... veteran, he spent thirty years in the Navy. Following his career as a ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( ), one ... an innovative new design of the shoulder pad. The shoulder pad provides optimal ... controlling your pain while using cold therapy. By utilizing ice and water that is ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... of 2017 on Tuesday, October 24, 2017. Lilly will ... the investment community and media to further detail the ... begin at 9 a.m. Eastern time. Investors, media and ... the conference call through a link that will be ...
(Date:9/28/2017)... -- Cohen Veterans Bioscience and Early Signal Foundation announce ... home sensors for real-time monitoring of patients with trauma-related ... organization focused on disruptive health solutions for rare disorders ... to record and integrate behavioral, cognitive, physiological and contextual ... ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
Breaking Medicine Technology: